December 21, 2010
European Neurologists Expect Significant Increases in the Use of Both Tysabri and Extavia in Their Multiple Sclerosis Patients the Next Six Months
- /
- /
Yahoo Finance Press Release – Source: BioTrends Research Group, Inc. On Tuesday December 21, 2010, EXTON, Pa., Dec. 21, 2010 /PRNewswire/ — BioTrends Research Group,…
